Cargando…

Clinical Practice Audit on the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis in the Netherlands

INTRODUCTION: Managing complex and rare systemic autoimmune diseases such as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) can be challenging and is often accompanied by undesirable variations in clinical practice. Adequate understanding of clinical practice can help identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dirikgil, Ebru, Jonker, Jacqueline T., Tas, Sander W., Verburgh, Cornelis A., Soonawala, Darius, Hak, A. Elisabeth, Remmelts, Hilde H.F., IJpelaar, Daphne, Laverman, Gozewijn D., Rutgers, Abraham, van Laar, Jacob M., Moen, Hein J. Bernelot, Verhoeven, Peter M.J., Rabelink, Ton J., Bos, Willem Jan W., Teng, Y.K. Onno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484125/ https://www.ncbi.nlm.nih.gov/pubmed/34622106 http://dx.doi.org/10.1016/j.ekir.2021.08.002

Ejemplares similares

Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients
por: Dirikgil, Ebru, et al.
Publicado: (2022)

Compassionate Use of Avacopan in Difficult-to-Treat Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
por: van Leeuwen, Jolijn R., et al.
Publicado: (2021)

ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial
por: Dirikgil, Ebru, et al.
Publicado: (2022)

Response to “Tailored Use of Avacopan in a Case With Refractory Antineutrophil Cytoplasmic Autoantibody-Associated Renal Vasculitis and Concominant Complement System Activation”
por: van Leeuwen, Jolijn R., et al.
Publicado: (2022)

PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
por: van Dam, Laura S, et al.
Publicado: (2020)

Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases
por: van Dam, Laura S., et al.
Publicado: (2018)

Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Compared to Systemic Lupus Erythematosus
por: van Dam, Laura S., et al.
Publicado: (2019)

Home monitoring reduced short stay admissions in suspected COVID-19 patients: COVID-box project
por: Dirikgil, Ebru, et al.
Publicado: (2021)

COVID-box Experiences of Patients and Health Care Professionals (COVID-box Project): Single-Center, Retrospective, Observational Study
por: Dirikgil, Ebru, et al.
Publicado: (2022)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial
por: van Schaik, Mieke, et al.
Publicado: (2022)

Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study
por: van der Velden, Anouk I M, et al.
Publicado: (2022)

Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein Intake
por: Oosterwijk, Milou M., et al.
Publicado: (2022)

Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis
por: Alba, Marco A., et al.
Publicado: (2022)

Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
por: van Leeuwen, Jolijn R, et al.
Publicado: (2023)

Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus
por: Oosterwijk, Milou M., et al.
Publicado: (2020)

Leg muscle strength is reduced and is associated with physical quality of life in Antineutrophil cytoplasmic antibody-associated vasculitis
por: Hessels, Arno C., et al.
Publicado: (2019)

Antineutrophil cytoplasmic antibodies in infective endocarditis: a case report and systematic review of the literature
por: Van Gool, Inge C., et al.
Publicado: (2022)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Antineutrophil cytoplasmic antibodies in myelodysplasia.
por: Hull, D. R., et al.
Publicado: (1996)

Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease
por: Dekker, Shosha E. I., et al.
Publicado: (2020)

Thiopurine methyltransferase genotype and activity cannot predict outcomes of azathioprine maintenance therapy for antineutrophil cytoplasmic antibody associated vasculitis: A retrospective cohort study
por: Hessels, Arno C., et al.
Publicado: (2018)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes
por: Gant, Christina M., et al.
Publicado: (2018)

Neutrophils are not consistently activated by antineutrophil cytoplasmic antibodies in vitro
por: Popat, Reena J, et al.
Publicado: (2019)

Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients
por: Dekker, Shosha E.I., et al.
Publicado: (2022)

Antineutrophil Cytoplasmic Antibody and Multiple Sclerosis
por: George, Jason C., et al.
Publicado: (2017)

Clinical and Dietary Determinants of Muscle Mass in Patients with Type 2 Diabetes: Data from the Diabetes and Lifestyle Cohort Twente
por: Jalving, Annis C., et al.
Publicado: (2021)

Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Gant, Christina M., et al.
Publicado: (2017)

Unveiling the role of Mfsd2a and LPC-DHA in kidney repair
por: Rietjens, Rosalie G.J., et al.
Publicado: (2023)

Spectrum of retinal abnormalities in renal transplant patients using chronic low-dose steroids
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors
por: Gant, Christina M., et al.
Publicado: (2018)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Antineutrophil Cytoplasmic Antibodies Associated With Infective Endocarditis
por: Langlois, Vincent, et al.
Publicado: (2016)

Antineutrophil properties of natural gingerols in models of lupus
por: Ali, Ramadan A., et al.
Publicado: (2021)

TAC-TIC use of tacrolimus-based regimens in lupus nephritis
por: Kraaij, Tineke, et al.
Publicado: (2016)

Inconvenience due to travelers' diarrhea: a prospective follow-up study
por: Soonawala, Darius, et al.
Publicado: (2011)

Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial
por: Binnenmars, S. Heleen, et al.
Publicado: (2019)

Glycaemic control in the diabetes and Lifestyle Cohort Twente: A cross‐sectional assessment of lifestyle and pharmacological management on Hba1c target achievement
por: Jalving, Annis C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_r0um7o4l87ljoul3k1kc3mcai8